Article Details

BioCure Technology to Develop ROR1-Targeted CAR-T Cell Therapy | Precision Oncology News

Retrieved on: 2021-08-30 17:26:15

Tags for this article:

Click the tags to see associated articles and topics

BioCure Technology to Develop ROR1-Targeted CAR-T Cell Therapy | Precision Oncology News. View article details on hiswai:

Excerpt

For several years, BiocurePharm, a subsidiary of the Vancouver-based BioCure Technology, has been advancing CD19-directed CAR T-cell therapies for acute ...

Article found on: www.precisiononcologynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up